Last edition
News about Industrial talks
Pharma Leaders Outline Key Expectations Ahead of Union Budget 2026
Pharma industry leaders are urging the government to simplify GST on essential medicines, improve ease of doing business, enable easier access to long-term capital and provide greater policy clarity, amid more, in the upcoming Union Budget 2026.
Industrial talks | 28/01/2026 | By News Bureau | 292
Telangana Unveils Life Sciences Policy 2026-30
Telangana has unveiled its Life Sciences Policy 2026–30 with an ambition to rank among the world’s top five life sciences clusters by 2030, targeting USD 25 billion in investments while shifting the sector’s focus toward innovation-led growth and higher value creation.
Industrial talks | 22/01/2026 | By News Bureau
Paracetamol Safe in Pregnancy, Confirms MHRA After Major Lancet Review Finds No Autism or ADHD Risk
The UK medicines regulator MHRA reaffirmed paracetamol as safe during pregnancy after a major Lancet review found no link to autism, ADHD or intellectual disability in children.
Industrial talks | 20/01/2026 | By News Bureau | 121
AstraZeneca Acquires Full Global Rights to AbelZeta's CAR-T Therapy C-CAR031 in USD 630 Million Deal
AstraZeneca has acquired AbelZeta Pharma’s China rights to CAR-T therapy C-CAR031 for up to USD 630 million, securing full global development and commercialisation rights for the liver cancer treatment.
Industrial talks | 20/01/2026 | By News Bureau
Concept Life Sciences has appointed Dr Adam Davenport as Chief Scientific Officer (CSO), who brings over 25 years of expertise in life sciences and partnership management to advance the company’s leadership in integrated drug discovery.
Industrial talks | 20/01/2026 | By News Bureau | 108
Brazil and Nigeria Emerge as High-Growth Markets for Indian Pharma Exports
During the April–November period of the current financial year, pharmaceutical exports to Nigeria recorded a sharp increase, making it one of the fastest-growing destinations for Indian drug makers.
Industrial talks | 19/01/2026 | By Darshana | 111
China's NMPA Approves Sanofi-Licensed Myqorzo and Redemplo for Rare Cardiac and Lipid Disorders
Myqorzo and Redemplo approvals by NMPA expand treatment options for obstructive hypertrophic cardiomyopathy and familial chylomicronaemia syndrome in adult patients across Greater China.
Industrial talks | 17/01/2026 | By News Bureau | 106
AbbVie Aligns Drug Development and Manufacturing Plans for Obesity Portfolio
AbbVie is moving to establish a strong presence in the obesity treatment market, with a strategy that emphasizes manufacturing scalability, supply readiness, and long-term production efficiency alongside clinical development.
Industrial talks | 16/01/2026 | By Darshana
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Industrial talks | 15/01/2026 | By News Bureau | 213
Eisai, Nuvation Bio Collaborates to Expand Taletrectinib's Global Reach
The collaboration between Eisai and Nuvation to expand global development and commercialisation of taletrectinib for ROS1-positive non-small cell lung cancer.
Industrial talks | 15/01/2026 | By News Bureau | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy